150
Participants
Start Date
February 28, 2027
Primary Completion Date
July 31, 2028
Study Completion Date
July 31, 2028
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)
Non-invasive vagus nerve stimulation will be delivered with a well-validated device. taVNS delivers stimulation on the left ear, with the placement of the stimulating electrode differing between the active and sham conditions. Stimulation will occur during each learning trial (total of 30 trials per phase).
Stanford University, Stanford
National Institute on Aging (NIA)
NIH
Stanford University
OTHER